NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products
Estimated value
£4.1m
Awarded value
£3.8m
Awarded 01 Jun 2016
Suppliers
1
Lots
1
1 awarded
Published
17 Aug 2018
Deadline 23 Mar 2016
Description
NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products. The framework will commence on 1st July 2016 to 31st March 2017, with options to extend for up to a further 39 months. Please refer to the ITO, Document No.05d for a list of Participating Authorities.
Scope
- Reference
- CM/PHS/16/5501
- Total value
- £4,124,999.8 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2016 to 31 Jan 2019
- CPV classifications
- 33141000 33621000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 23 Mar 2016, 12:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£3.8m
Award date
01 Jun 2016
Contract start
30 Jun 2016
Contract end
31 Jan 2019